Skip to main content
Headache launches the publication of plain language summaries.
Caution regarding fabricated citations from artificial intelligence.
Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.
Benefits and implications of integrating artificial intelligence in manuscripts submitted to Headache.
Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review.
Bridging the gap between preclinical scientists, clinical researchers, and clinicians: From animal research to clinical practice.
Diagnosing new daily persistent headache in children and adolescents: A survey of clinicians.
Advancing our commitment to our peer reviewers.
Migraine treatment and COVID-19 vaccines: No cause for concern.
Would chronotype change the impact of the relationship between early school schedules and adolescent migraine frequency? A response.